Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. 

Biotechnology

Y-mAbs Therapeutics

Thomas Gad

Courtney Dugan

Tore Søderblom

Sune Nyland

Søren Christensen

Rikke Lillesø

René Christensen

Christopher Naylor

Anna Murzhenko, PharmD

Vignesh Rajah

Bo Kruse

Joris Wilms

Sue Smith

The executive team at Y-mAbs Therapeutics has a history of working in regional offices for research, clinical trial services, and development. They also have experience as a technical assistant, vice president, director, partner, CEO, and president. Most of the team members have a medical background, with a few having a biochemistry background.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Y-mAbs Therapeutics

Leadership Team

Board of Directors